Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BLRX |
---|---|---|
09:32 ET | 2843 | 0.631 |
09:38 ET | 700 | 0.6322 |
09:39 ET | 239 | 0.631 |
09:45 ET | 6400 | 0.631 |
09:48 ET | 313 | 0.638 |
09:50 ET | 1605 | 0.6311 |
09:54 ET | 1715 | 0.635 |
09:59 ET | 2600 | 0.6399 |
10:03 ET | 300 | 0.6425 |
10:06 ET | 4100 | 0.6475 |
10:12 ET | 1600 | 0.64 |
10:30 ET | 1000 | 0.6497 |
10:32 ET | 250 | 0.644899 |
10:37 ET | 250 | 0.6448 |
10:42 ET | 100 | 0.6449 |
11:13 ET | 1118 | 0.6447 |
11:22 ET | 600 | 0.6423 |
11:56 ET | 100 | 0.6425 |
11:58 ET | 1234 | 0.6425 |
12:03 ET | 201 | 0.641 |
12:16 ET | 500 | 0.6419 |
12:18 ET | 500 | 0.6442 |
12:23 ET | 100 | 0.6427 |
12:32 ET | 200 | 0.6427 |
12:59 ET | 400 | 0.6442 |
01:01 ET | 100 | 0.6431 |
01:08 ET | 2800 | 0.642 |
01:48 ET | 3629 | 0.632 |
01:50 ET | 900 | 0.6419 |
02:42 ET | 150 | 0.6417 |
02:56 ET | 100 | 0.6412 |
03:02 ET | 200 | 0.6412 |
03:03 ET | 100 | 0.631 |
03:18 ET | 827 | 0.64 |
03:34 ET | 1644 | 0.6404 |
03:36 ET | 2941 | 0.641 |
03:38 ET | 700 | 0.6405 |
03:39 ET | 500 | 0.64045 |
03:43 ET | 2100 | 0.638 |
03:48 ET | 4300 | 0.6301 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
BioLine RX Ltd | 52.7M | -0.7x | --- |
Palatin Technologies Inc | 37.0M | -1.0x | --- |
Kezar Life Sciences Inc | 56.3M | -0.5x | --- |
Kronos Bio Inc | 61.3M | -0.5x | --- |
Correlate Energy Corp | 50.6M | -3.8x | --- |
Dyadic International Inc | 42.4M | -6.3x | --- |
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $52.7M |
---|---|
Revenue (TTM) | $4.8M |
Shares Outstanding | 79.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.51 |
EPS | $-0.95 |
Book Value | $0.18 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | 11.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,035.29% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.